TY - JOUR
T1 - EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on valvular heart disease and the European Association of Cardiovascular Imaging endorsed cby the Heart Rhythm Society, by the Asia Pacific Heart Rhythm Society, and by the Latin American Heart Rhythm Society
AU - Sabbag, Avi
AU - Essayagh, Benjamin
AU - Barrera, Juan David Ramírez
AU - Basso, Cristina
AU - Berni, Ana
AU - Cosyns, Bernard
AU - Deharo, Jean Claude
AU - Deneke, Thomas
AU - Di Biase, Luigi
AU - Enriquez-Sarano, Maurice
AU - Donal, Erwan
AU - Imai, Katsuhiko
AU - Lim, Han S.
AU - Marsan, Nina Ajmone
AU - Turagam, Mohit K.
AU - Peichl, Petr
AU - Po, Sunny S.
AU - Haugaa, Kristina Hermann
AU - Shah, Dipen
AU - de Riva Silva, Marta
AU - Bertrand, Philippe
AU - Saba, Magdi
AU - Dweck, Marc
AU - Townsend, Santiago Nava
AU - Ngarmukos, Tachapong
AU - Fenelon, Guilherme
AU - Santangeli, Pasquale
AU - Sade, Leyla Elif
AU - Corrado, Domenico
AU - Lambiase, Pier
AU - Sanders, Prashanthan
AU - Delacrétaz, Etienne
AU - Jahangir, Arshad
AU - Kaufman, Elizabeth S.
AU - Saggu, Daljeet Kaur
AU - Pierard, Luc
AU - Delgado, Victoria
AU - Lancellotti, Patrizio
N1 - Publisher Copyright:
© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved.
PY - 2022/12/1
Y1 - 2022/12/1
N2 - Graphical Abstract Risk stratification scheme. Risk stratification aiming at assessing the risk of VAs and SCD in patients with MVP, involving two phases based on the clinical and imaging context and the uncovered arrhythmia. In the absence of ventricular tachycardia, phenotypic risk features will trigger the intensity of screening for arrhythmia. Green boxes indicate green heart consensus statements and yellow boxes indicate yellow heart consensus statements. High risk - sustained VT, polymorphic NSVT, fast (>180 bpm) NSVT, VT/NSVT resulting in syncope. ICD = implantable cardioverter defibrillator; LA = left atrium; LGE = late gadolinium enhancement; LV-EF = left ventricular ejection fraction; MAD = mitral annular disjunction; MV = mitral valve; PVCs = premature ventricular contractions; TWI = T-wave inversion; VT = ventricular tachycardia. #Additional ECG monitoring method may be used such as loop recorders.
AB - Graphical Abstract Risk stratification scheme. Risk stratification aiming at assessing the risk of VAs and SCD in patients with MVP, involving two phases based on the clinical and imaging context and the uncovered arrhythmia. In the absence of ventricular tachycardia, phenotypic risk features will trigger the intensity of screening for arrhythmia. Green boxes indicate green heart consensus statements and yellow boxes indicate yellow heart consensus statements. High risk - sustained VT, polymorphic NSVT, fast (>180 bpm) NSVT, VT/NSVT resulting in syncope. ICD = implantable cardioverter defibrillator; LA = left atrium; LGE = late gadolinium enhancement; LV-EF = left ventricular ejection fraction; MAD = mitral annular disjunction; MV = mitral valve; PVCs = premature ventricular contractions; TWI = T-wave inversion; VT = ventricular tachycardia. #Additional ECG monitoring method may be used such as loop recorders.
KW - Mitral valve prolapse Mitral annular disjunction Sudden cardiac death Ventricular arrhythmia Risk stratification
UR - https://www.scopus.com/pages/publications/85142034945
U2 - 10.1093/europace/euac125
DO - 10.1093/europace/euac125
M3 - Article
C2 - 35951656
AN - SCOPUS:85142034945
SN - 1099-5129
VL - 24
SP - 1981
EP - 2003
JO - Europace
JF - Europace
IS - 12
ER -